I sold too soon but I owned shares before the buyo
Post# of 148173
(Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire Immunomedics, Inc. (Nasdaq: IMMU) for approximately $21 billion in the aggregate. ... Pursuant to the terms of the merger agreement, Purchaser merged with and into Immunomedics on
GILD knows they need a better drug. They clearly know their days are numbered….